April 18-20, Rome Annual EuroPRevent 2013 was held.
Ai Mediq S.A. took part in the tradeshow presenting the new model of its Reoxy Normobaric Interval Hypoxic Treatment device. Our visitors had an excellent opportunity to undergo hypoxic test with subsequent treatment sessions. Our specialists provided advice regarding the usage of ReOxy as well as distributed recent publications regarding the newly developed treatment method.
As a part of the scientific programme, Prof. Oleg Glazachev presented a report entitled "Interval normobaric hypoxic-hyperoxic training increases exercise tolerance in patients with coronary artery disease", outlining the results of clinical trials performed at Moscow Regional Cardiological Center under supervision of Prof. YU Pozdnyakov.
Pictures from the official EuroPRevent 2013 Facebook album are posted here.